butylscopolammonium bromide has been researched along with Sclerosis, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregersen, H; Hendel, L; Storkholm, JH; Villadsen, GE; Vilstrup, H | 1 |
1 other study(ies) available for butylscopolammonium bromide and Sclerosis, Systemic
| Article | Year |
|---|---|
Impedance planimetric characterization of esophagus in systemic sclerosis patients with severe involvement of esophagus.
Topics: Adult; Aged; Butylscopolammonium Bromide; Cholinergic Antagonists; Esophageal Diseases; Esophagus; Female; Humans; Male; Manometry; Middle Aged; Peristalsis; Scleroderma, Systemic | 1997 |